Virus Like Particles Market Size And Share

  • Report Code : TIPRE00025763
  • Category : Biotechnology
  • Status : Published
  • No. of Pages : 163
Buy Now

Virus-Like Particles Market Share, Size, and Trends by 2028

Buy Now

Virus-Like Particles Market Report Virus-Like Particles Market Scope and Analysis Virus-Like Particles Market Size and Share

Virus-Like Particles Market: Strategic Insights

Virus-Like Particles Market

  • CAGR (2021 - 2028)
    7.9%
  • Market Size 2021
    US$ 4.6 Billion
  • Market Size 2028
    US$ 7.86 Billion

Market Dynamics

GROWTH DRIVERS
  • Rising demand for vaccine development.
  • Increasing investments in biotech research.
  • Growing prevalence of infectious diseases.
FUTURE TRENDS
  • Rise in personalized VLP vaccines.
  • Nanotechnology in VLP development.
  • Focus on scalable VLP production.
OPPORTUNITIES
  • Expansion in cancer vaccine research.
  • Development of VLP-based diagnostics.
  • Increasing applications in gene therapy.

Key Players

  • Merck Co Inc
  • GlaxoSmithKline plc
  • Pfizer Inc
  • Dynavax Technologies
  • Sanofi
  • Wantai BioPharm
  • Serum Institute of India Pvt Ltd
  • BHARAT BIOTECH
  • LG Chem

Regional Overview

  • North America
  • Europe
  • Asia-Pacific
  • South and Central America
  • Middle East and Africa

Market Segmentation

Product Type
  • Hepatitis
  • Cancer
Source
  • Yeast
  • Insect cells
Application
  • Vaccine
  • Therapeutics and Imaging Agents